National Cancer Institute selects Kaiser Permanente for new Cancer Screening Research Network
The National Cancer Institute, part of the National Institutes of Health, selected Kaiser Permanente Northern California as one of the institutions to launch a new national clinical trials network to evaluate emerging technologies for cancer screening.
National Academy of Medicine selects Elizabeth Cespedes Feliciano as Emerging Leader in Health and Medicine Scholar
Kaiser Permanente research scientist who studies modifiable risk factors for obesity and cancer-related metabolic diseases is one of 10 early- to mid-career professionals chosen for the class of 2023.
Kaiser Permanente research included in national clinical oncology conference
Investigators from the Division of Research and physicians from The Permanente Medical Group presented research on topics ranging from care delivery to cancer survivorship at the 2023 American Society of Clinical Oncology conference.
Podcast: Improving lung cancer survival
In this episode of KP Research Radio, Lori Sakoda, PhD, a research scientist at the Division of Research, and Jeff Velotta, MD, a thoracic surgeon with The Permanente Medical Group, discuss early lung cancer detection, ways to promote equitable lung cancer care, and Kaiser Permanente Northern California’s regionalized lung cancer care program.
New radiology reporting system decreased time to pancreatic cancer diagnoses
A new Kaiser Permanente study shows that having radiologists use standardized terms and hashtags to describe what they see creates a clearer path for physician follow-up that can lead to earlier detection of pancreatic cancer.
Diverse new class of postdoctoral fellows adds to research strength
The Kaiser Permanente Division of Research postdoctoral research program drew one of its largest-ever classes of fellows this year, building the strength of DOR’s research portfolio. Seven fellows cover fields from diet to dementia, cancer to clinical informatics, to women’s and children’s health, and more.
American Indian, Alaska Native women less likely to start and complete hormone therapy for breast cancer
Kaiser Permanente study, believed to be the first to look at hormone therapy initiation and adherence in this population, suggests lower rates of use may be contributing to higher breast cancer death rates.
Unique genetic factors and ancestry, along with lifestyle, influence skin cancer risk
People can look to the Northern European side of their genetic heritage for increased risk of nonmelanoma skin cancer, according to the first large analysis of genetic risk factors for cutaneous squamous cell carcinoma in diverse populations with European ancestry from Kaiser Permanente researchers.
Home recovery after surgery is now a mainstay for mastectomy patients
In this new episode of KP Research Radio, we talk with Brooke Vuong, MD, a breast cancer surgeon at the Kaiser Permanente South Sacramento Medical Center, about her research on the Surgical Home Recovery Program and the impact the program has had on her patients.
Early colorectal cancer screening benefits African Americans
Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.
David Baer, MD: A passion for cancer research
David Baer, MD, cofounded the KP Oncology Clinical Trials program in the 1980s. He has enrolled significant numbers of patients in these trials, and helped expand the regional effort into a national KP program. As a leading member of the Northern California Central Research Committee for most of his career, he provides valuable experience in the practicality of research within Kaiser Permanente.
More metastatic prostate cancers found after change in screening guidelines
In the years after the U.S. Preventive Services Task Force recommended against PSA-based screening in all men, many fewer men were diagnosed with prostate cancer but more were found to have advanced cancers, according to a large Kaiser Permanente study published today in the Journal of General Internal Medicine.
Body fatness affects chemo dosages, contributing to increased risk of breast cancer death
Women with greater adiposity, or body fatness, were significantly less likely to receive all of the recommended chemotherapy dose to treat their breast cancer, and they were subsequently 30% more likely to die from the disease as a result, according to research published in JAMA Oncology.
Medical imaging rates continue to rise despite push to reduce their use
Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase in both the United States and Ontario, Canada, according to a new study of more than 135 million imaging exams.
Kaiser Permanente research shows mastectomy patients recover safely at home
A study in Annals of Surgical Oncology finds that the rate of home recovery after mastectomy increased from 23% regionwide to 61% in the 6 months after the program started, with no significant changes in emergency-department visits, reoperations, or readmissions.
Use of CT scans during pregnancy increased in U.S. and Canada over 2 decades
A large, multicenter study of advanced medical imaging in pregnancy, published in JAMA Network Open and co-led by Marilyn Kwan, PhD, found that CT scans were performed in 0.8% of pregnancies in the United States and 0.4% in Ontario in 2016; these rates increased nearly fourfold in the United States and doubled in Ontario over the 21 years.
New study data suggests revising heart disease management guidelines for colon cancer survivors
“This study demonstrates the importance at every BMI level of having more precise measures of muscle and fat to help identify those patients who are at high risk of developing cardiovascular disease,” said co-author Bette J. Caan, DrPH.
Work by the Division of Research Makes Top JAMA Lists for 2018
The JAMA Network, the publication home for numerous top-tier journals from the American Medical Association, released a list of the “Most Talked About Articles” in each of their various publications for 2018. DOR research appears on four lists.
Kaiser Permanente Study Finds 10-Year Follow-up Interval After Negative Colonoscopies Is Associated with Reduced Risk of Colorectal Cancer and Mortality
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal cancer screening.
A Better Way to Assess Ovarian Cancer Risk
New radiology guidelines developed by Kaiser Permanente gynocological oncologist and researcher Betty Suh-Burgman, MD, allow women at higher risk for ovarian cancer to be promptly referred for surgical evaluation while women at low risk can safely avoid surgery.
Kaiser Permanente Receives $7 Million to Better Identify Those at Risk of Getting Cancer
A research team at the Kaiser Permanente Northern California Division of Research has been awarded $7 million that will allow them to assess three different methods for acquiring and acting on family history, from initial acquisition to final results.
Integrated Colorectal Cancer Screening Program Saves Lives
Kaiser Permanente members in Northern California are 52 percent less likely to die from colorectal cancer since the health care system launched a comprehensive, organized screening program, according to a new study in the specialty’s top journal, Gastroenterology.
Division of Research’s Theodore Levin, MD, honored for colorectal cancer screening program
DOR’s Theodore (TR) Levin, MD, is one of four recipients of The Permanente Medical Group’s 2018 Sidney R. Garfield Exceptional Contribution Awards, for pioneering efforts to expand colorectal cancer screening.
NCI Funds New 5-year, $16M, Program to Understand Barriers to Colorectal Cancer Screening
Researchers at the Kaiser Permanente Northern California Division of Research will lead a consortium evaluating colorectal cancer as part of the NCI’s Population-based Research to Optimize the Screening Process program.
Urban American-Indian and Alaskan Natives May Have Lower Survival Following Invasive Prostate and Breast Cancer
Compared with the non-Hispanic white (NHW) population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer, according to results published by Kaiser Permanente researchers and colleagues in Cancer Research, a journal of the American Association for Cancer Research.
World’s Most Impactful Researchers List Includes Kaiser Permanente Northern California Scientist and Oncologist
Alan Go, MD, of the Kaiser Permanente Division of Research, and Kaiser Permanente Northern California oncologist Louis Fehrenbacher, MD, are among the less than 400 people named as Highly Cited Researchers in clinical medicine for 2017 by Clarivate Analytics. The annual list recognizes investigators whose research ranks in the top 1 percent most cited works in their field, indicating exceptional scientific impact.
Translating Research Into Improved Women’s Health Care
Elizabeth “Betty” Suh-Burgmann, MD, says her latest research project was “born out of frustration with the state of affairs” for managing adnexal masses in women. Like gynecological oncologists across the nation, she saw many women at her Kaiser Permanente Walnut Creek practice undergo surgeries to determine whether small masses in their ovaries were benign or cancerous.